Position in MYGN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$211,966
+$8,895 QoQ
Shares Held
37,122
-17.7% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#97
of 197 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MYGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026AXQ CAPITAL, LP holds $7,683,167 across 10 Diagnostics & Research names. MYGN ranks #7 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MTD |
Mettler Toledo International Inc/
|
2,100 | $2,682,771 | |
| 2 | QGEN |
Qiagen N.V.
|
36,910 | $1,443,181 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
2,104 | $1,054,861 | |
| 4 | LH |
Labcorp Holdings Inc.
|
3,602 | $1,008,560 | |
| 5 | DHR |
Danaher Corp /De/
|
3,623 | $690,109 | |
| 6 | DGX |
Quest Diagnostics Inc
|
1,697 | $359,679 | |
| 7 | MYGN |
Myriad Genetics Inc
This page
|
37,122 | $211,966 | |
| 8 | XGN |
Exagen Inc.
|
27,948 | $129,958 |
All Filings in MYGN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $211,966 | 37,122 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $203,071 | 45,127 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $96,499 | 15,691 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $82,769 | 11,448 | Shares | Sole | 2025-11-10 | |
| No filing history on record for this holder in this stock. | ||||||